Inflammatory cytokines and type I 5'-deiodinase expression in Phi(1) rat liver cells

被引:14
作者
Davies, PH
Sheppard, MC
Franklyn, JA
机构
[1] Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston
基金
英国医学研究理事会;
关键词
type 1 5'-deiodinase; cytokines; liver cells; TUMOR-NECROSIS-FACTOR; THYROID-HORMONE METABOLISM; FACTOR-ALPHA-CACHECTIN; IODOTHYRONINE DEIODINASE; NONTHYROIDAL ILLNESS; CONTINUOUS-INFUSION; INTERLEUKIN-6; RELEASE; ENDOTOXIN; ENZYME;
D O I
10.1016/S0303-7207(97)04058-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Administration of tumour necrosis factor-alpha (TNF alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) to animals and humans results in changes in circulating thyroid hormone concentrations similar to those seen in non-thyroidal illness (NTI). Inflammatory cytokines have been postulated as mediators of the euthyroid sick syndrome by inhibiting type 1 5'-deiodinase (5'D-I) enzyme activity. We have investigated direct effects of cytokines upon 5'D-I expression, measuring changes in 5'D-I enzyme activity and mRNA in Phi(1) rat liver cells. All three cytokines stimulated 5'D-I enzyme activity: TNF alpha 326 +/- 43% (100% in controls, mean + S.E.M., n = 9, P < 0.01 by ANOVA), IL-1 beta 297 +/- 8% and IL-6 272 +/- 25%. Co-incubation with cycloheximide abolished stimulation by each cytokine. Kinetic analysis revealed that stimulation of 5'D-I enzyme activity was a result of significantly increased V-max, (P <0.01 by ANOVA) with K-m relatively unchanged. 5'D-I mRNA abundance was not significantly changed following treatment by any of the three cytokines. These findings do not support the hypothesis that inflammatory cytokines may mediate the euthyroid sick syndrome by causing inhibition of 5'D-I activity. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 36 条
[1]   EFFECTS OF INTERLEUKIN-6 ON THE EXPRESSION OF THYROID HORMONE-BINDING PROTEIN GENES IN CULTURED HUMAN HEPATOBLASTOMA-DERIVED (HEP-G2) CELLS [J].
BARTALENA, L ;
FARSETTI, A ;
FLINK, IL ;
ROBBINS, J .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (06) :935-942
[2]   THE IODOTHYRONINE DEIODINASES AND 5'-DEIODINATION [J].
BECKETT, GJ ;
ARTHUR, JR .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1994, 8 (02) :285-304
[3]   TYPE-I IODOTHYRONINE DEIODINASE IS A SELENOCYSTEINE-CONTAINING ENZYME [J].
BERRY, MJ ;
BANU, L ;
LARSEN, PR .
NATURE, 1991, 349 (6308) :438-440
[4]  
BERRY MJ, 1994, THYROID HORMONE METABOLISM, P1
[5]  
BOELEN A, 1993, J CLIN ENDOCR METAB, V77, P1695, DOI 10.1210/jcem.77.6.8263160
[6]   INTERLEUKIN-1 IMMUNOREACTIVE INNERVATION OF THE HUMAN HYPOTHALAMUS [J].
BREDER, CD ;
DINARELLO, CA ;
SAPER, CB .
SCIENCE, 1988, 240 (4850) :321-324
[7]   THE THYROID-GLAND IS A MAJOR SOURCE OF CIRCULATING-T(3) IN THE RAT [J].
CHANOINE, JP ;
BRAVERMAN, LE ;
FARWELL, AP ;
SAFRAN, M ;
ALEX, S ;
DUBORD, S ;
LEONARD, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2709-2713
[8]   A STUDY OF THE SERUM CONCENTRATION OF TUMOR-NECROSIS-FACTOR-ALPHA IN THYROIDAL AND NONTHYROIDAL ILLNESSES [J].
CHOPRA, IJ ;
SAKANE, S ;
TECO, GNC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (05) :1113-1116
[9]   Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness [J].
Davies, PH ;
Black, EG ;
Sheppard, MC ;
Franklyn, JA .
CLINICAL ENDOCRINOLOGY, 1996, 44 (02) :199-205
[10]  
DAVIES PH, 1996, THYROID, V6, P213